Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...
Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsPatrick Miles - Executive Chairman, CEO ...
Alphatec Holdings, Inc. (NASDAQ:ATEC) Q4 2025 Earnings Call Transcript February 24, 2026 Alphatec Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.1448 EPS, expectations were $0.04.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results